Podcasts by RMD Open: Rheumatic and Musculoskeletal Diseases

COVID-19 and cytokines - same storm, different origins? from 2020-06-10T16:53:56

In this podcast, Caroline Ospelt (Department of Rheumatology, University Hospital of Zurich, Switzerland) talks to Alessia Alunno (Rheumatology Unit, University of Perugia, Italy) about the similar...

Imaging in large vessel vasculitis from 2018-11-09T08:18:03

A systematic literature review on imaging techniques for diagnosis, outcome prediction and disease monitoring in large vessel vasculitis informing the European League Against Rheumatism recommendat...

The use of MRI in rheumatology from 2018-09-18T09:08:56

RMD Open Editor-in-Chief Professor Bernard Combe talks to Professor Annette van der Helm from Leiden University Medical Center about the use of MR imaging in the diagnosis and classification of rhe...

Improving the peer review skills of young researchers in rheumatology from 2018-08-10T14:05:52

What is peer-review and why is important? EMEUNET, the Emerging EULAR (European League Against Rheumatism) Network, organises a training program in collaboration with the EULAR journals to improve ...

Don’t neglect nutrition in rheumatoid arthritis! from 2018-06-13T20:30:07

What mistakes should be avoided in our diet? And what potentially beneficial foods should we be taking? The answers are given by Professor Maurizio Cutolo (Postgraduate School of Rheumatology, Univ...

A standardised catalogue of patient scenarios to improve the ranking of RA disease activity? from 2018-05-18T20:30:38

To better standardise the evaluation of disease activity of rheumatoid arthritis patients, especially in moderate disease, consensus scores of their medical doctor (MD) global ratings (EGA) are nee...

Osteoarthritis or rheumatoid? The MDHAQ patient questionnaire role in routine rheumatology care from 2018-03-13T14:37

Editor-in-Chief of RMD Open Bernard Combe is joined by Theodore Pincus, Rheumatologist at the Rush University, Chicago, to discuss how new screening tools such as the MDHAQ (Multidimensional Health...

Sjögren's syndrome: what do we know so far? from 2018-01-25T00:39:25

Professor Xavier Mariette (Head of Rheumatology at Université Paris-Sud, France) is an expert in Sjögren's syndrome. He tells Editor-in-Chief of RMD Open Bernard Combe what is known so far about a ...

Rheumatic immune-related adverse events of checkpoint therapy for cancer from 2017-12-06T22:08:03

Cassandra Calabrese (Cleveland Clinic Foundation, Ohio, USA) speaks with Editor-in-Chief of RMD Open Bernard Combe about checkpoint inhibitors. For more information, please visit the RMD Open websi...

Branded drug or biosimilar? Reasons to adopt generics in rheumatology, by Professor Jonathan Kay from 2017-11-06T17:26:22

Professor Jonathan Kay (Division of Rheumatology, Department of Medicine, University of Massachusetts Medical School and UMass Memorial Medical Center, Worcester, Massachusetts, USA) tells Editor-i...

Early diagnosis and treatment: the Rheumatic Diseases Portuguese Register from 2017-07-17T08:26:21

Dr Joao Fonseca, head of the Rheumatology Department at the Lisbon Academic Medical Centre (Faculdade de Medicina da Universidade de Lisboa), tells Editor in Chief of RMD Open Bernard Combe how th...

Interleukin-17: a role in inflammatory arthritis and implication for clinical practice from 2017-05-05T15:14:14

Interleukin-17 (IL-17A) is a cytokine critical for the acute defence against extracellular bacterial and fungal infections. Excess production during chronic inflammation has been associated with ma...

Welcome to RMD Open from 2015-02-04T11:52:31

BMJ and EULAR are launching a new rheumatic and musculoskeletal diseases journal, RMD Open, and Editor-in-Chief Bernard Combe explains what readers and authors can look forward to.

http://rmdopen...